Apigenin-7-O-β-D-glucuronide prophylaxis ameliorates allergic airway inflammation by suppressing the TCF4-mediated Syk pathway
{{output}}
Background: Asthma has traditionally been characterized by persistent airway inflammation. Innovative therapeutic target and specific pharmacologic intervention remain essential for effectively managing inflammatory condition. ... ...
